Royalty Pharma RPRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $586.4M-5.2% | $618.7M-34.1% | $938.94M+48.6% | $631.91M-41.9% | $1.09B+17.1% | ||
| $21.9M+16.5% | $18.8M+16.8% | $16.1M+22.0% | $13.2M+9.1% | $12.1M-79.2% | ||
| $20.04B-2.0% | $20.46B+1.8% | $20.09B+3.4% | $19.44B+0.1% | $19.41B+2,377% | ||
| $10.16M+47.4% | $6.89M+24.9% | $5.52M+24.0% | $4.45M+44.6% | $3.08M-26.5% | ||
| $1.43B-6.7% | $1.53B-17.4% | $1.85B+21.7% | $1.52B-17.5% | $1.84B+2.3% | ||
| $924.63M0.0% | $924.63M0.0% | $924.63M0.0% | $924.63M— | —— | ||
| $16.54B+2.1% | $16.21B+2.8% | $15.76B+4.2% | $15.13B+0.7% | $15.03B-0.6% | ||
| $265.7M-8.4% | $289.97M-0.3% | $290.96M+5.5% | $275.91M-17.9% | $336.21M-11.4% | ||
| $406.8M-2.9% | $419M+38.5% | $302.5M+11.3% | $271.9M+24.2% | $219M-68.4% | ||
| $173.27M+1.1% | $171.31M+32.4% | $129.39M+17.1% | $110.53M-21.7% | $141.08M-24.5% | ||
| $17.32B+1.5% | $17.06B+2.6% | $16.62B+4.0% | $15.98B+1.5% | $15.75B-1.0% | ||
| $19.82B+1.0% | $19.62B+1.4% | $19.35B+5.6% | $18.32B+4.1% | $17.61B-3.4% | ||
| $25.48M+31.3% | $19.4M-53.1% | $41.42M+105% | $20.21M-46.3% | $37.63M+181% | ||
| $17.48M-67.1% | $53.16M+1,603% | $3.12M+1.5% | $3.08M-83.5% | $18.6M-72.9% | ||
| $380M0.0% | $380M0.0% | $380M-62.0% | $999.44M+0.1% | $998.61M+0.1% | ||
| $18.49M-4.0% | $19.26M-3.8% | $20.02M-3.6% | $20.77M— | —— | ||
| $25.3M-77.2% | $110.82M+282% | $29.04M-66.1% | $85.61M+345% | $19.22M-80.4% | ||
| $535.68M-15.8% | $636.21M+19.9% | $530.8M-56.0% | $1.21B+2.0% | $1.18B-5.6% | ||
| $8.58B+0.1% | $8.57B+0.1% | $8.57B+22.3% | $7B+5.8% | $6.62B+0.1% | ||
| $18.49M-4.0% | $19.26M-3.8% | $20.02M-3.6% | $20.77M— | —— | ||
| $117.79M-2.5% | $120.84M-4.8% | $126.94M-11.4% | $143.33M+701% | $17.9M+48.2% | ||
| $9.88B-0.3% | $9.91B+1.8% | $9.73B+10.3% | $8.82B+12.8% | $7.82B-0.8% | ||
| $4.38B+6.3% | $4.12B+0.3% | $4.11B-0.4% | $4.13B-2.0% | $4.21B+2.6% | ||
| $2.51B+6.4% | $2.36B+2.3% | $2.3B+3.7% | $2.22B-10.4% | $2.48B-12.8% | ||
| $2.71M+3.7% | $2.61M0.0% | $2.61M0.0% | $2.61M-1.6% | $2.65M-0.3% | ||
| $3.05B-5.9% | $3.24B+1.0% | $3.21B+1.6% | $3.16B+1.8% | $3.1B-8.7% | ||
| $9.94B+2.3% | $9.71B+1.0% | $9.62B+1.2% | $9.5B-2.8% | $9.78B-5.5% | ||
| $19.82B+1.0% | $19.62B+1.4% | $19.35B+5.6% | $18.32B+4.1% | $17.61B-3.4% | ||
| $2.72B-19.9% | $3.4B-2.1% | $3.47B+0.4% | $3.46B-5.6% | $3.66B-3.4% | ||
| $21.9M+16.5% | $18.8M+16.8% | $16.1M+22.0% | $13.2M+9.1% | $12.1M-79.2% | ||
| $10.16M+47.4% | $6.89M+24.9% | $5.52M+24.0% | $4.45M+44.6% | $3.08M-26.5% | ||
| $27.51M-6.2% | $29.32M+1.4% | $28.9M+4.2% | $27.74M+16.6% | $23.79M-11.8% | ||
| $20.04B-2.0% | $20.46B+1.8% | $20.09B+3.4% | $19.44B+0.1% | $19.41B-1.5% | ||
| $779.84M-8.7% | $854.39M-0.7% | $860.07M+2.0% | $842.94M+17.6% | $716.56M-8.6% | ||
| $17.32B+1.5% | $17.06B+2.6% | $16.62B+4.0% | $15.98B+1.5% | $15.75B-1.0% | ||
| $17.32B+1.5% | $17.06B+2.6% | $16.62B+4.0% | $15.98B+1.5% | $15.75B-1.0% | ||
| $17.32B+1.5% | $17.06B+2.6% | $16.62B+4.0% | $15.98B+1.5% | $15.75B-1.0% | ||
| $76.85M-3.1% | $79.29M-8.4% | $86.59M+1.3% | $85.49M+133% | $36.71M+9.5% | ||
| $16.54B+2.1% | $16.21B+2.8% | $15.76B+4.2% | $15.13B+0.7% | $15.03B-0.6% | ||
| $173.27M+1.1% | $171.31M+32.4% | $129.39M+17.1% | $110.53M-21.7% | $141.08M-24.5% | ||
| $173.27M+1.1% | $171.31M+32.4% | $129.39M+17.1% | $110.53M-21.7% | $141.08M-24.5% | ||
| $406.8M-2.9% | $419M+38.5% | $302.5M+11.3% | $271.9M+24.2% | $219M-68.4% | ||
| $16.54B+2.1% | $16.21B+2.8% | $15.76B+4.2% | $15.13B+0.7% | $15.03B-0.6% | ||
| $76.85M-3.1% | $79.29M-8.4% | $86.59M+1.3% | $85.49M+133% | $36.71M+9.5% | ||
| $76.85M-3.1% | $79.29M-8.4% | $86.59M+1.3% | $85.49M+133% | $36.71M+9.5% | ||
| $25.48M+31.3% | $19.4M-53.1% | $41.42M+105% | $20.21M-46.3% | $37.63M+181% | ||
| $87.42M+20.0% | $72.83M-5.7% | $77.22M-21.4% | $98.2M-9.7% | $108.8M+43.5% | ||
| $17.48M-67.1% | $53.16M+1,603% | $3.12M+1.5% | $3.08M-83.5% | $18.6M-72.9% | ||
| $3.04M— | —— | $1.01M-49.9% | $2.02M— | —— | ||
| $3.72M— | —— | $3.78M0.0% | $3.78M— | —— | ||
| $3.76M— | —— | $3.73M0.0% | $3.73M— | —— | ||
| $3.72M— | —— | $3.78M0.0% | $3.78M— | —— | ||
| $3.73M— | —— | $3.72M0.0% | $3.72M— | —— | ||
| $3.76M— | —— | $3.73M0.0% | $3.73M— | —— | ||
| $3.79M— | —— | $4.05M0.0% | $4.05M— | —— | ||
| $21.16M— | —— | $23.17M-4.2% | $24.18M— | —— | ||
| $2.67M— | —— | $3.15M-7.6% | $3.41M— | —— | ||
| $223.56M-2.4% | $229.08M-2.2% | $234.27M+32.0% | $177.5M-2.8% | $182.55M-2.7% | ||
| $3.73M— | —— | $3.72M0.0% | $3.72M— | —— | ||
| $3.73M— | —— | $3.72M0.0% | $3.72M— | —— | ||
| $3.76M— | —— | $3.73M0.0% | $3.73M— | —— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | $33.12— | —— | ||
| $1.7B— | —— | $1.9B-5.0% | $2B-13.0% | $2.3B— | ||
| $1.7B— | —— | $1.9B-5.0% | $2B-13.0% | $2.3B— | ||
| $20.04B-2.0% | $20.46B+1.8% | $20.09B+3.4% | $19.44B+0.1% | $19.41B-1.5% | ||
| $648.67M+12.3% | $577.87M+14.9% | $502.94M+7.7% | $467.14M— | —— | ||
| 100%— | —— | 100%0.0% | 100%0.0% | 100%— | ||
| 1— | —— | 10.0% | 10.0% | 1— | ||
| $223.56M-2.4% | $229.08M-2.2% | $234.27M+32.0% | $177.5M-2.8% | $182.55M-2.7% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 427.4M+3.9% | 411.5M+0.4% | 409.9M+0.2% | 409M+3.7% | 394.5M+0.6% | ||
| 427.4M+3.9% | 411.5M+0.4% | 409.9M+0.2% | 409M+3.7% | 394.5M+0.6% | ||
| $265.7M-8.4% | $289.97M-0.3% | $290.96M+5.5% | $275.91M-17.9% | $336.21M-11.4% | ||
| $2.52B-21.0% | $3.19B-2.0% | $3.25B+0.3% | $3.24B-5.7% | $3.44B-3.2% | ||
| $204.91M-3.3% | $211.96M-4.0% | $220.69M+1.8% | $216.71M-3.5% | $224.62M-5.7% | ||
| $17.53B+1.5% | $17.27B+2.6% | $16.84B+4.0% | $16.19B+1.4% | $15.97B-1.1% | ||
| $21.16M— | —— | $23.17M-4.2% | $24.18M— | —— | ||
| $3.13M— | —— | $6.88M0.0% | $6.88M— | —— | ||
| $2.67M— | —— | $3.15M-7.6% | $3.41M— | —— | ||
| $3.05B-5.9% | $3.24B+1.0% | $3.21B+1.6% | $3.16B+1.8% | $3.1B-8.7% | ||
| 2— | —— | 20.0% | 20.0% | 2— | ||
| 4— | —— | 40.0% | 4+33.3% | 3— | ||
| $825M— | —— | —— | —— | —— | ||
| $600M— | —— | —— | —— | —— | ||
| —— | —— | —— | $33.12— | —— | ||
| —— | —— | —— | —— | $3B— | ||
| $1.7B— | —— | $1.9B-5.0% | $2B-13.0% | $2.3B— | ||
| $3.04M— | —— | $1.01M-49.9% | $2.02M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Royalty Pharma's total assets?
- Royalty Pharma (RPRX) holds $19.8B in total assets, up 12.5% year over year.
- How much debt does Royalty Pharma have?
- Royalty Pharma carries $9.0B in total debt against $9.9B of shareholders' equity, a debt-to-equity ratio of 0.90.
- How much cash does Royalty Pharma have?
- Royalty Pharma holds $586.4M in cash and equivalents.
- Can Royalty Pharma cover its short-term obligations?
- Its current ratio is 2.66 — current assets exceed current liabilities.
- Where does Royalty Pharma's balance sheet data come from?
- Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
